Bill Text: IL SR0957 | 2015-2016 | 99th General Assembly | Introduced
Bill Title: Urges all private and public high schools, colleges, and universities in the State of Illinois to provide information to all students and parents about meningococcal disease, explaining the different disease serogroups, symptoms, risks, treatments, and the availability, benefits, risks, and limitations of all meningococcal vaccines. Urges each private and public high school, college, and university in the State to recommend that current and entering students receive meningococcal vaccines in accordance with current Advisory Committee on Immunization Practices guidelines.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2016-05-27 - Resolution Adopted [SR0957 Detail]
Download: Illinois-2015-SR0957-Introduced.html
| |||||||
| |||||||
| |||||||
1 | SENATE RESOLUTION
| ||||||
2 | WHEREAS, Meningococcal disease is any infection caused by | ||||||
3 | the bacterium Neisseria meningitidis, or meningococcus; | ||||||
4 | although 1 in 10 people are carriers for this bacteria with no | ||||||
5 | signs or symptoms of disease, sometimes Neisseria meningitidis | ||||||
6 | bacteria can cause illness; and
| ||||||
7 | WHEREAS, Meningococcal disease is spread from person to | ||||||
8 | person via the exchange of the bacteria through respiratory and | ||||||
9 | throat secretion during close or lengthy contact; and
| ||||||
10 | WHEREAS, There are approximately 1,000 to 1,200 cases of | ||||||
11 | meningococcal disease that occur in the United States each | ||||||
12 | year; 10-15% of infected individuals will die, while 11-19% of | ||||||
13 | those who live will suffer from serious morbidity, including | ||||||
14 | loss of limbs and impacts to the nervous system; and
| ||||||
15 | WHEREAS, Infants under one year of age and young adults | ||||||
16 | between the ages of 16 and 21 are most commonly impacted by | ||||||
17 | this disease; and
| ||||||
18 | WHEREAS, There are different strains or serogroups of | ||||||
19 | Neisseria meningitidis, with serogroups B, C, and Y accounting | ||||||
20 | for most meningococcal diseases in the United States; and
|
| |||||||
| |||||||
1 | WHEREAS, There have been several recent outbreaks of | ||||||
2 | serogroup B meningococcal disease on college campuses, with | ||||||
3 | some cases resulting in death; and
| ||||||
4 | WHEREAS, Vaccines are available to prevent meningococcal | ||||||
5 | disease; different vaccines provide coverage against certain | ||||||
6 | specific serogroups of the disease; and
| ||||||
7 | WHEREAS, While there are vaccines that help provide | ||||||
8 | protection against all 3 serogroups (B, C, and Y) commonly seen | ||||||
9 | in the United States, only vaccination for serogroups A, C, W, | ||||||
10 | and Y is routinely recommended by the Centers for Disease | ||||||
11 | Control and Prevention; and
| ||||||
12 | WHEREAS, The Centers for Disease Control and Prevention's | ||||||
13 | Advisory Committee on Immunization Practices recommends that | ||||||
14 | decisions to vaccinate adolescents and young adults 16 through | ||||||
15 | 23 years of age against serogroup B meningococcal disease | ||||||
16 | should be made at the individual level with health care | ||||||
17 | providers; and
| ||||||
18 | WHEREAS, It is critical that students, parents, educators, | ||||||
19 | and health care providers understand the dangers of meningitis | ||||||
20 | B and are aware that a vaccine is available to prevent disease | ||||||
21 | resulting from this serogroup; and
|
| |||||||
| |||||||
1 | WHEREAS, The recent incidences of meningococcal disease | ||||||
2 | has served as a reminder of the critical role vaccinations play | ||||||
3 | in helping to prevent this devastating illness; therefore, be | ||||||
4 | it
| ||||||
5 | RESOLVED, BY THE SENATE OF THE NINETY-NINTH GENERAL | ||||||
6 | ASSEMBLY OF THE STATE OF ILLINOIS, that we urge all private and | ||||||
7 | public high schools, colleges, and universities in the State of | ||||||
8 | Illinois to provide information to all students and parents | ||||||
9 | about meningococcal disease, explaining the different disease | ||||||
10 | serogroups, symptoms, risks, and treatments; and be it further
| ||||||
11 | RESOLVED, That such information should also include a | ||||||
12 | notice of availability, benefits, risks, and limitations of all | ||||||
13 | meningococcal vaccines receiving a recommendation from the | ||||||
14 | Advisory Committee on Immunization Practices, including | ||||||
15 | Category A and Category B recommendations, with specific | ||||||
16 | information as to those persons at higher risk for the disease; | ||||||
17 | and be it further
| ||||||
18 | RESOLVED, That we urge each private and public high school, | ||||||
19 | college, and university in the State to recommend that current | ||||||
20 | and entering students receive meningococcal vaccines in | ||||||
21 | accordance with current Advisory Committee on Immunization | ||||||
22 | Practices guidelines; and be it further
|
| |||||||
| |||||||
1 | RESOLVED, That suitable copies of this resolution be made | ||||||
2 | available to all private and public high schools, colleges, and | ||||||
3 | universities in the State.
|